HRP970094A2 - 1,4-dihydropyridine compounds - Google Patents

1,4-dihydropyridine compounds

Info

Publication number
HRP970094A2
HRP970094A2 HRPCT/IB96/00132A HRP970094A HRP970094A2 HR P970094 A2 HRP970094 A2 HR P970094A2 HR P970094 A HRP970094 A HR P970094A HR P970094 A2 HRP970094 A2 HR P970094A2
Authority
HR
Croatia
Prior art keywords
dihydropyridine compounds
dihydropyridine
compounds
Prior art date
Application number
HRPCT/IB96/00132A
Other languages
English (en)
Inventor
Ikeda Takafumi
Original Assignee
Ikeda Takafumi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikeda Takafumi filed Critical Ikeda Takafumi
Publication of HRP970094A2 publication Critical patent/HRP970094A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
HRPCT/IB96/00132A 1996-02-19 1997-02-18 1,4-dihydropyridine compounds HRP970094A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600132 1996-02-19

Publications (1)

Publication Number Publication Date
HRP970094A2 true HRP970094A2 (en) 1998-06-30

Family

ID=11004406

Family Applications (1)

Application Number Title Priority Date Filing Date
HRPCT/IB96/00132A HRP970094A2 (en) 1996-02-19 1997-02-18 1,4-dihydropyridine compounds

Country Status (34)

Country Link
US (1) US6131226A (fr)
EP (1) EP0882044B1 (fr)
JP (1) JP3167335B2 (fr)
KR (1) KR19990082678A (fr)
CN (1) CN1211251A (fr)
AR (1) AR005841A1 (fr)
AT (1) ATE220676T1 (fr)
AU (1) AU1396497A (fr)
BG (1) BG102678A (fr)
BR (1) BR9707568A (fr)
CA (1) CA2245857C (fr)
CO (1) CO4650041A1 (fr)
CZ (1) CZ258698A3 (fr)
DE (1) DE69714019T2 (fr)
DK (1) DK0882044T3 (fr)
ES (1) ES2177921T3 (fr)
HN (1) HN1997000013A (fr)
HR (1) HRP970094A2 (fr)
HU (1) HUP9902810A3 (fr)
ID (1) ID16434A (fr)
IL (1) IL124867A0 (fr)
IS (1) IS4783A (fr)
MA (1) MA26419A1 (fr)
NO (1) NO983776D0 (fr)
NZ (1) NZ325455A (fr)
OA (1) OA10712A (fr)
PE (1) PE36298A1 (fr)
PL (1) PL328514A1 (fr)
PT (1) PT882044E (fr)
SI (1) SI0882044T1 (fr)
TN (1) TNSN97037A1 (fr)
TR (1) TR199801593T2 (fr)
WO (1) WO1997030048A1 (fr)
ZA (1) ZA971357B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) * 2004-12-14 2005-01-12 3M Innovative Properties Co Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (fr) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines utilisees comme antagonistes de bradykinine
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.

Also Published As

Publication number Publication date
HN1997000013A (es) 1997-06-26
CN1211251A (zh) 1999-03-17
PT882044E (pt) 2002-11-29
SI0882044T1 (en) 2002-10-31
JPH11507949A (ja) 1999-07-13
IS4783A (is) 1998-06-25
EP0882044B1 (fr) 2002-07-17
DE69714019D1 (de) 2002-08-22
CZ258698A3 (cs) 1999-06-16
BR9707568A (pt) 1999-07-27
TR199801593T2 (xx) 1999-12-21
MA26419A1 (fr) 2004-12-20
ATE220676T1 (de) 2002-08-15
ES2177921T3 (es) 2002-12-16
HUP9902810A2 (hu) 2000-05-28
DK0882044T3 (da) 2002-09-02
KR19990082678A (ko) 1999-11-25
NZ325455A (en) 1999-07-29
DE69714019T2 (de) 2002-11-14
NO983776L (no) 1998-08-18
US6131226A (en) 2000-10-17
WO1997030048A1 (fr) 1997-08-21
ZA971357B (en) 1998-08-18
HUP9902810A3 (en) 2000-09-28
CO4650041A1 (es) 1998-09-03
IL124867A0 (en) 1999-01-26
OA10712A (en) 2001-06-04
NO983776D0 (no) 1998-08-18
BG102678A (en) 1999-04-30
CA2245857A1 (fr) 1997-08-21
PE36298A1 (es) 1998-07-18
AU1396497A (en) 1997-09-02
ID16434A (id) 1997-09-25
PL328514A1 (en) 1999-02-01
CA2245857C (fr) 2002-10-01
EP0882044A1 (fr) 1998-12-09
TNSN97037A1 (fr) 2005-03-15
JP3167335B2 (ja) 2001-05-21
AR005841A1 (es) 1999-07-14

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
HUP9903965A3 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
ZA9711092B (en) Novel compounds.
GB9607120D0 (en) Compounds
ZA95462B (en) Substitute 1,2,3,4-tetrahydro -5-nitro-pyrimidines
ZA9711567B (en) Compounds.
ZA975861B (en) Bromotiacumicin compounds.
GB9602326D0 (en) Compounds
ZA971357B (en) 1,4-dihydropyridine compounds
AUPP003297A0 (en) 4,5-diaryloxazole compounds
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
ZA979404B (en) Aspirinate compounds.
ZA965384B (en) 4-Amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
GB9606933D0 (en) Compounds
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
ZA97415B (en) Novel compounds.
ZA975696B (en) Novel compounds.
GB9815537D0 (en) 2,6-Quinolines
GB9607121D0 (en) Compounds
GB9607215D0 (en) Compounds
GB9606931D0 (en) Compounds
GB9604638D0 (en) Compounds
GB9603432D0 (en) Compounds

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 19990218

Year of fee payment: 3

ODBC Application rejected